Aurobindo Pharma to attend Goldman Sachs investor meet
Aurobindo Pharma Limited officials will participate in a group investor meeting organized by Goldman Sachs on June 12, 2026, in Hyderabad. The meeting, part of the Goldman Sachs CRO/CDMO Tour, is scheduled from 03:30 PM to 05:00 PM IST. The company stated that no unpublished price sensitive information (UPSI) will be discussed during the interactions, though the schedule remains subject to change.
*this image is generated using AI for illustrative purposes only.
Aurobindo Pharma Limited officials will participate in a group investor meeting organized by Goldman Sachs on June 12, 2026. The meeting is scheduled to be held in Hyderabad from 03:30 PM to 05:00 PM IST. The company clarified that no unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The participation is part of the Goldman Sachs CRO/CDMO Tour. The schedule of the meeting remains subject to change due to exigencies on the part of the investor or the company.
The following table outlines the details of the meeting:
| Date | Time | Investor/Meeting name | Type of meeting | Location |
|---|---|---|---|---|
| June 12, 2026 | 03:30 PM to 05:00 PM (IST) | Goldman Sachs CRO/CDMO Tour | Group meeting | Hyderabad |
Historical Stock Returns for Aurobindo Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.72% | +1.65% | -1.56% | +24.86% | +25.04% | +51.88% |
What strategic updates might Aurobindo Pharma share regarding its CRO/CDMO capabilities during the meeting?
How could this investor meeting influence Aurobindo Pharma's stock performance in the short term?
What are the potential market implications of Aurobindo's participation in the Goldman Sachs CRO/CDMO Tour?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
